510(k) K233605 · LLM Test, Antigen, Nuclear, Epstein-Barr Virus
ADVIA Centaur EBV-EBNA IgG
| Applicant | Biokit, S.A., Lliçà DAmunt, Barcelona, ES |
| Decision | Substantially Equivalent, Aug 7, 2024 |
| Received | Nov 9, 2023 |
| Type | Traditional |
| FDA record | Open on fda.gov |
Recalls that name K233605
No recall in the FDA data names this 510(k).
Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.